Loyal Lovin readers can support Lovin so we can continue to share the stories of all amazing cities
Minimum custom amount to enter is AED 2
By donating, you agree to the Privacy Policy and Terms of Service
Saudi Just Approved Its First-Ever Alzheimer’s Drug And It’s A Big Deal For Regional Healthcare
Saudi Just Approved Its First-Ever Alzheimer’s Drug And It’s A Big Deal For Regional Healthcare
Saudi Arabia just hit a historic medical milestone
The Saudi Food and Drug Authority (SFDA) has officially approved Leqembi (lecanemab), a breakthrough treatment for early-stage Alzheimer’s disease. The green light came on July 29, 2025, making this the first Alzheimer’s drug ever approved in the Kingdom – and it’s more than just a regulatory move, it’s a game-changer for patients and science alike.
Saudi Just Approved Its First-Ever Alzheimer’s Drug And It’s A Big Deal For Regional Healthcare
This is no ordinary pill—it’s a monoclonal antibody treatment designed for individuals in the early stages of Alzheimer’s
Recommended
Saudi Medical Team Begins Major Orthopedic Surgeries In Sudan
Travis Scott Circus Maximus Tour Hits Ahmad bin Ali Stadium on May 16th
Ed Sheeran, OneRepublic And More Set To Rock The Stage In Abu Dhabi!particularly those who have mild cognitive impairment or early Alzheimer’s-type dementia. It specifically targets amyloid-beta plaques in the brain—those sticky clumps linked to memory loss and cognitive decline. Leqembi is given through IV infusion every two weeks, and studies have shown it can slow cognitive decline when used early. But it’s not for everyone—patients must undergo genetic testing to determine if they have zero or one copy of the ApoE4 gene, which affects both the drug’s effectiveness and risk profile.
Saudi Just Approved Its First-Ever Alzheimer’s Drug And It’s A Big Deal For Regional Healthcare
A step forward in personalized medicine
With potential side effects like headaches, infusion reactions, and ARIA (abnormal changes seen on MRI scans), the SFDA isn’t taking any risks. Ongoing safety monitoring and a risk management plan are mandatory, ensuring patient safety stays front and center.
Lovin Riyadh Newsletter 